Akebia Therapeutics Inc. buy Piper Sandler
Start price
31.05.23
/
50%
€0.92
Target price
31.05.24
-
Performance (%)
13.76%
End price
01.06.24
€1.05
Summary
This prediction ended on 01.06.24 with a price of €1.05. The prediction had a final performance of 13.76%. Piper_Sandler has a follow-up prediction for Akebia Therapeutics Inc. where he still thinks Akebia Therapeutics Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | -2.956% | -2.956% | -44.385% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by Piper_Sandler for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.97
14.03.25
14.03.25
€5.53
14.03.26
14.03.26
-40.40%
06.02.26
06.02.26
Stopped prediction by Piper_Sandler for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.15
06.02.26
06.02.26
€3.39
06.02.27
06.02.27
-
06.02.26
06.02.26